Apart from PD, LRRK2 has also been linked to cancer (Ruiz-Martínez et al., 2014), inflammatory bowel disorder (IBD) (Jostins et al., 2012), multibacillary leprosy (Zhang et al., 2009), and functionally with tuberculosis (Härtlova et al., 2018). This evidence concerns the gene LRRK2 and cancer.